{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:06:16Z","timestamp":1784696776329,"version":"3.55.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Drug resistance in\n                    <jats:italic>Mycobacterium<\/jats:italic>\n                    species, particularly\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , remains a protracted and severe challenge to global public health. Recent studies have revealed that heteroresistance, serving as a critical precursor stage to full resistance, plays a pivotal role in treatment failure and disease relapse. Heteroresistance is characterized by the co-existence of susceptible and resistant subpopulations within a single bacterial population; however, due to the low proportion of the resistant subpopulation, it is highly susceptible to being missed in routine clinical diagnosis. This review summarizes the genetic and phenotypic mechanisms underlying the emergence of heteroresistance in\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , evaluates the utility of various molecular detection technologies in identifying heteroresistance, and discusses its impact on clinical treatment regimen adjustments and the evolutionary trajectory of drug resistance. Ultimately, this review aims to provide a theoretical foundation for optimizing individualized, precision treatment for patients infected with\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1894646","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:41:18Z","timestamp":1784695278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Heteroresistance in Mycobacterium tuberculosis: from molecular mechanisms and advanced detection to clinical implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Shibo","family":"Liu","sequence":"first","affiliation":[{"name":"Open Laboratory, Hangzhou Xixi Hospital, Hangzhou Sixth People\u2019s Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[{"name":"Open Laboratory, Hangzhou Xixi Hospital, Hangzhou Sixth People\u2019s Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Open Laboratory, Hangzhou Xixi Hospital, Hangzhou Sixth People\u2019s Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Zhu","sequence":"additional","affiliation":[{"name":"Open Laboratory, Hangzhou Xixi Hospital, Hangzhou Sixth People\u2019s Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3916980","article-title":"Relationships between efflux pumps and emergence of heteroresistance: a comprehensive study on the current findings","volume":"2022","author":"Abavisani","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12864-024-10697-1","article-title":"Sequencing by binding rivals SMOR error-corrected sequencing by synthesis technology for accurate detection and quantification of minor (< 0.1%) subpopulation variants","volume":"25","author":"Allender","year":"2024","journal-title":"BMC Genomics"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.612675","article-title":"Evolution of drug-resistant Mycobacterium tuberculosis strains and their adaptation to the human lung environment","volume":"12","author":"Allu\u00e9-Guardia","year":"2021","journal-title":"Front. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21608\/aprh.2023.193384.1212","article-title":"Heteroresistance: a gray side of antimicrobial susceptibility testing","volume":"7","author":"Al-Shebiny","year":"2023","journal-title":"J. Adv. Pharm. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.70608\/j8dmhg15","article-title":"Tinjauan literatur tentang hubungan mutasi genetik dengan resistensi obat pada Mycobacterium tuberculosis","volume":"2","author":"Amukti","year":"2024","journal-title":"J. Pharm. Halal Stud."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/biology12040525","article-title":"Heteroresistance of Mycobacterium tuberculosis in the sputum detected by droplet digital PCR","volume":"12","author":"Aung","year":"2023","journal-title":"Biology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1042\/bcj20200194","article-title":"The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host\u2019s immune system","volume":"477","author":"Batt","year":"2020","journal-title":"Biochem. J."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/genes15111424","article-title":"TERTmonitor efficacy and performance in detecting mutations by droplet digital PCR","volume":"15","author":"Bessa-Gon\u00e7alves","year":"2024","journal-title":"Genes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0358-2025","article-title":"Evaluation of T-NGS, Xpert Ultra, and Line Probe Assay on clinical samples for the diagnosis of drug-resistant pulmonary tuberculosis in Rio de Janeiro","volume":"58","author":"Bhering","year":"2025","journal-title":"Rev. Soc Bras. Med. Trop."},{"key":"B11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.it.2023.07.003","article-title":"Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye","volume":"44","author":"Bobba","year":"2023","journal-title":"Trends Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/labmed2040026","article-title":"Current antibiotic susceptibility test underestimates minority resistance: implications for high-risk infections","volume":"2","author":"Brukner","year":"2025","journal-title":"LabMed"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006939","article-title":"TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities","volume":"14","author":"Carey","year":"2018","journal-title":"PloS Pathog."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105875","article-title":"Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis","volume":"15","author":"Carpi","year":"2025","journal-title":"EBioMedicine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa071","article-title":"The within-host evolution of antimicrobial resistance in Mycobacterium tuberculosis","volume":"45","author":"Castro","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00812-17","article-title":"The new Xpert MTB\/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12866-025-04601-4","article-title":"A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis","volume":"26","author":"Chang","year":"2025","journal-title":"BMC Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1166\/mex.2020.1615","article-title":"Phenotype and genotype heterogeneous resistance of L-forms of Mycobacterium tuberculosis by magnetic nanoparticle","volume":"10","author":"Chen","year":"2020","journal-title":"Mater. Express"},{"key":"B20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/infdis\/jiab011","article-title":"Lesion heterogeneity and long-term heteroresistance in multidrug-resistant tuberculosis","volume":"224","author":"Chen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102120","article-title":"Deep whole-genome sequencing reveals no evidence for heteroresistance influencing treatment outcomes among drug-susceptible tuberculosis patients","volume":"130","author":"Chen","year":"2021","journal-title":"Tuberculosis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13061306","article-title":"Whole-genome sequence analysis to assess mutations in efflux pumps in Mycobacterium tuberculosis: the influence in drug resistance","volume":"13","author":"Chimal-Mu\u00f1oz","year":"2025","journal-title":"Microorganisms"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.70675\/8da3f3a2z198bz489dz9519zc8e6029107b0","article-title":"Application of nanoparticles for the development of new antituberculosis therapies","author":"Costa Gouveia","year":"2017","journal-title":"Universit\u00e9 du Droit la Sant\u00e9 - Lille II"},{"key":"B24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5588\/ijtldopen.24.0343","article-title":"Impact of heteroresistance on treatment outcomes of people with drug-resistant TB","volume":"1","author":"Crowder","year":"2024","journal-title":"IJTLD Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/thorax-2023-220202","article-title":"Challenging the gold standard: the limitations of molecular assays for detection of Mycobacterium tuberculosis heteroresistance","volume":"79","author":"Danchuk","year":"2024","journal-title":"Thorax"},{"key":"B27","unstructured":"Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia\n          \n          \n            \n              Daniel Mekonnen\n              D. M.\n            \n            \n              Aschalew Admassu\n              A. A.\n            \n            \n              Wondemagegn Mulu\n              W. M.\n            \n            \n              Aranzazu Amor\n              A. A.\n            \n            \n              Agust\u00edn Benito\n              A. B.\n            \n            \n              Woynshet Gelaye\n              W. G.\n            \n          \n          \n          2015"},{"key":"B28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4103\/ijmy.ijmy_132_20","article-title":"Characterization of Mycobacterium tuberculosis heteroresistance by genotyping","volume":"9","author":"de Assis Figueredo","year":"2020","journal-title":"Int. J. Mycobacteriology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"00630","DOI":"10.1183\/23120541.00630-2025","article-title":"Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant Mycobacterium tuberculosis: an in-depth comparison","volume":"12","author":"de Diego Fuertes","year":"2026","journal-title":"ERJ Open Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.molcel.2019.09.028","article-title":"Bacterial heterogeneity and antibiotic survival: understanding and combatting persistence and heteroresistance","volume":"76","author":"Dewachter","year":"2019","journal-title":"Mol. Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/ijmy.ijmy_116_23","article-title":"Fluoroquinolone resistance mutations among Mycobacterium tuberculosis and their interconnection with treatment outcome","volume":"12","author":"Dixit","year":"2023","journal-title":"Int. J. Mycobacteriology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5588\/ijtld.15.0221","article-title":"Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET\/RESIST-TB consensus statement","volume":"20","author":"Dom\u00ednguez","year":"2016","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cmi.2017.05.026","article-title":"Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment","volume":"24","author":"Driesen","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2026.115049","article-title":"Screening for heterogeneous drug resistance in tuberculosis and its impact on clinical prognosis: a comprehensive review","volume":"29","author":"Du","year":"2026","journal-title":"iScience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41579-019-0273-7","article-title":"The mycobacterial cell envelope\u2014a moving target","volume":"18","author":"Dulberger","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1165\/rcmb.2019-0178LE","article-title":"Minority Mycobacterium tuberculosis genotypic populations as an indicator of subsequent phenotypic resistance","volume":"61","author":"Engelthaler","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","article-title":"Drug-resistant tuberculosis: a persistent global health concern","volume":"22","author":"Farhat","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tube.2011.12.007","article-title":"Mycobacterium tuberculosis\u2013heterogeneity revealed through whole genome sequencing","volume":"92","author":"Ford","year":"2012","journal-title":"Tuberculosis"},{"key":"B40","first-page":"799","article-title":"Un desaf\u00edo terap\u00e9utico: la heterorresistencia en Mycobacterium tuberculosis","volume":"83","author":"Gamberale","year":"2023","journal-title":"Med. B. Aires"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115397","article-title":"Analytical performance of the Xpert MTB\/XDR\u00ae assay for tuberculosis and expanded resistance detection","volume":"101","author":"Georghiou","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijregi.2021.12.007","article-title":"Genotypic and phenotypic drug-resistance detection and prevalence of heteroresistance in patients with isoniazid-and multidrug-resistant tuberculosis in Ethiopia","volume":"2","author":"Getahun","year":"2022","journal-title":"IJID Reg."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01671-24","article-title":"Xpert MTB\/RIF Ultra-resistant and MTBDR plus- susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing","volume":"69","author":"Ghebrekristos","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab541","article-title":"Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data","volume":"23","author":"Goossens","year":"2022","journal-title":"Brief. Bioinform."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120469","article-title":"Targeted next-generation sequencing for rapid tuberculosis detection: a systematic review and meta-analysis","volume":"577","author":"Gou","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/infdis\/jiaa625","article-title":"Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment","volume":"225","author":"Hjort","year":"2022","journal-title":"J. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.pathol.2023.03.002","article-title":"Evaluation of Xpert MTB\/RIF Ultra assay for detection of Mycobacterium tuberculosis and rifampicin resistance","volume":"55","author":"Huang","year":"2023","journal-title":"Pathol. (Phila.)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jmoldx.2020.06.010","article-title":"Specific gyrA gene mutations correlate with high prevalence of discordant levofloxacin resistance in Mycobacterium tuberculosis isolates from Beijing, China","volume":"22","author":"Huo","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00356-25","article-title":"Unpacking bedaquiline heteroresistance: the importance of intermediate profiles for phenotypic drug susceptibility testing","volume":"69","author":"Ismail","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03127-24","article-title":"Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance when applied in paucibacillary clinical samples","volume":"13","author":"Jin","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B52","unstructured":"Heteroresistance-from clinical implications to genetic mechanisms\n          \n          \n            \n              Jonsson\n              S.\n            \n          \n          Acta Universitatis Upsaliensis\n          \n          2025"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs","volume":"57","author":"Jouet","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/srep41410","article-title":"Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients","volume":"7","author":"Kargarpour Kamakoli","year":"2017","journal-title":"Sci. Rep."},{"key":"B55","unstructured":"Detecting mixed Mycobacterium tuberculosis infections and differences in drug susceptibility with WGS data\n          \n          \n            \n              Keo\n              A.\n            \n          \n          \n          2016"},{"key":"B56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5145\/ACM.2025.28.4.7","article-title":"Drug susceptibility testing for Mycobacterium tuberculosis: a narrative review","volume":"28","author":"Kim","year":"2025","journal-title":"Ann. Clin. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201632119","article-title":"Chemical\u2013genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy","volume":"119","author":"Koh","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12879-023-08968-5","article-title":"Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda","volume":"24","author":"Komakech","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.58838\/2075-1230-2025-103-6-17-23","article-title":"Potential of modern methods of rifampicin susceptibility testing in detection of heteroresistance of Mycobacterium tuberculosis cultures","volume":"6","author":"Lavrenchuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2021.05.001","article-title":"Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance","volume":"30","author":"Laws","year":"2022","journal-title":"Trends Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1038\/s41467-025-61703-3","article-title":"Trehalose catalytic shift inherently enhances phenotypic heterogeneity and multidrug resistance in Mycobacterium tuberculosis","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12088-025-01522-8","article-title":"Bacterial L-forms: key mechanisms of drug resistance, disease recurrence, and immune evasion","volume":"45","author":"Lei","year":"2025","journal-title":"Indian J. Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","article-title":"CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/nm.4205","article-title":"Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis","volume":"22","author":"Lieberman","year":"2016","journal-title":"Nat. Med."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2534656","article-title":"Mixed infections and heteroresistance of Mycobacterium tuberculosis among multidrug-resistant tuberculosis in China: a genomic epidemiology study","volume":"14","author":"Liu","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"B67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/0974-777x.157237","article-title":"Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosis","volume":"7","author":"Madhuri","year":"2015","journal-title":"J. Glob. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/aac.00583-24","article-title":"Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis","volume":"68","author":"Maitre","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxaf100","article-title":"Current diagnosing strategies for Mycobacterium tuberculosis and its drug resistance: a review","volume":"136","author":"Mao","year":"2025","journal-title":"J. Appl. Microbiol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011000","article-title":"High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: evidence for heteroresistance","volume":"19","author":"Martinecz","year":"2023","journal-title":"PloS Comput. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1074\/mcp.ra118.000821","article-title":"Biochemical characterization of isoniazid-resistant Mycobacterium tuberculosis: can the analysis of clonal strains reveal novel targetable pathways","volume":"17","author":"Mehaffy","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-020-00726-5","article-title":"Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex","volume":"12","author":"Merker","year":"2020","journal-title":"Genome Med."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.990312","article-title":"Transcriptional regulation and drug resistance in Mycobacterium tuberculosis","volume":"12","author":"Miotto","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01026-25","article-title":"Updated Erdman reveals tandem repeat copy number is phase-variable and impacts Mtb adaptation across evolutionary timescales","volume":"11","author":"Modlin","year":"2026","journal-title":"mSystems"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/25310429.2026.2632467","article-title":"Management of nontuberculous mycobacterial pulmonary disease refractory to guideline-based therapy: a systematic review","volume":"32","author":"Moreira-Sousa","year":"2026","journal-title":"Pulmonology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"10.1128\/jcm.00717","DOI":"10.1128\/jcm.00717-19","article-title":"How well do routine molecular diagnostics detect rifampin heteroresistance in Mycobacterium tuberculosis","volume":"57","author":"Ng","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102747","article-title":"Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment","volume":"55","author":"Nimmo","year":"2020","journal-title":"EBioMedicine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.956607","article-title":"Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation","volume":"12","author":"Parbhoo","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1155\/ijm\/8659735","article-title":"Evaluation of Xpert MTB\/XDR and Deeplex Myc-TB for the rapid detection of drug resistance in Mycobacterium tuberculosis","volume":"2026","author":"Park","year":"2026","journal-title":"Int. J. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03559-21","article-title":"The role of fatty acid metabolism in drug tolerance of Mycobacterium tuberculosis","volume":"13","author":"Quinonez","year":"2022","journal-title":"mBio"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37136","article-title":"Molecular characterization of katG and inhA mutations by genotype MTBDRplus line probe assay to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"15","author":"Ranjan","year":"2023","journal-title":"Cureus"},{"key":"B86","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Sci. Rep."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01701-23","article-title":"Reduced critical concentration might not have improved MGIT-based DST\u2019s sensitivity to rifampicin","volume":"68","author":"Rupasinghe","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.958555","article-title":"Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance","volume":"12","author":"Samuels","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa118","article-title":"CopyDetective: detection threshold\u2013aware copy number variant calling in whole-exome sequencing data","volume":"9","author":"Sandmann","year":"2020","journal-title":"GigaScience"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1274175","article-title":"Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host","volume":"13","author":"Schami","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"267","DOI":"10.56042\/ijbb.v62i3.13739","article-title":"Transport mediated antibiotic resistance in Mycobacterium tuberculosis","volume":"62","author":"Sharma","year":"2025","journal-title":"Indian J. Biochem. Biophys. IJBB"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2139\/ssrn.3155634","article-title":"Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity","volume":"25","author":"Shi","year":"2018","journal-title":"Cell Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/infdis\/jiy480","article-title":"Mixed Mycobacterium tuberculosis\u2013strain infections are associated with poor treatment outcomes among patients with newly diagnosed tuberculosis, independent of pretreatment heteroresistance","volume":"218","author":"Shin","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","article-title":"Prevalence and factors associated with multidrug-resistant tuberculosis in South India","volume":"10","author":"Shivekar","year":"2020","journal-title":"Sci. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s44259-024-00052-5","article-title":"Antibiotic resistance mediated by gene amplifications","volume":"2","author":"Silva","year":"2024","journal-title":"NPJ Antimicrob. Resist."},{"key":"B98","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12864-018-4988-z","article-title":"Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence data","volume":"19","author":"Sobkowiak","year":"2018","journal-title":"BMC Genomics"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02520-20","article-title":"Microevolution of Mycobacterium tuberculosis subpopulations and heteroresistance in a patient receiving 27 years of tuberculosis treatment in Germany","volume":"65","author":"Sonnenkalb","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.001396","article-title":"Gene conversion and duplication contribute to genetic variation in an outbreak of Mycobacterium tuberculosis","volume":"11","author":"Stritt","year":"2025","journal-title":"Microb. Genomics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1101\/2025.09.09.673684","article-title":"Cell cycle dependent variation in endocytosis drives phenotypic diversity in Mtb","author":"Subhash","year":"2025","journal-title":"bioRxiv"},{"key":"B102","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1046\/j.1365-2958.2000.01905.x","article-title":"Variable human minisatellite\u2010like regions in the Mycobacterium tuberculosis genome","volume":"36","author":"Supply","year":"2000","journal-title":"Mol. Microbiol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105645","article-title":"Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers","volume":"113","author":"Sury","year":"2025","journal-title":"EBioMedicine"},{"key":"B104","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s13318-024-00910-7","article-title":"Precision medicine strategies to improve isoniazid therapy in patients with tuberculosis","volume":"49","author":"Thomas","year":"2024","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/mjdrdypu.mjdrdypu_392_21","article-title":"Assessment of resistance to second line anti-tubercular drugs by line probe assay at a tertiary care hospital","volume":"16","author":"Thosani","year":"2023","journal-title":"Med. J. Dr DY Patil Vidyapeeth"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00982-19","article-title":"Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana","volume":"63","author":"Wang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/IDR.S405987","article-title":"Metabolic profiles of clinical isolates of drug-susceptible and multidrug-resistant Mycobacterium tuberculosis: A metabolomics-based study","volume":"16","author":"Wang","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00720-21","article-title":"Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis","volume":"65","author":"Werngren","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","unstructured":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update\n          \n          \n          World Health Organization\n          \n          2013"},{"key":"B80","unstructured":"WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment 2022 update\n          \n          \n          World Health Organization\n          \n          2022"},{"key":"B81","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance\n          \n          \n          World Health Organization\n          \n          2023"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00947","article-title":"Mild nutrient starvation triggers the development of a small-cell survival morphotype in mycobacteria","volume":"7","author":"Wu","year":"2016","journal-title":"Front. Microbiol."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02605-22","article-title":"Development and assessment of a novel whole-gene-based targeted next-generation sequencing assay for detecting the susceptibility of Mycobacterium tuberculosis to 14 drugs","volume":"10","author":"Wu","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s44259-025-00076-5","article-title":"Epidemiology, mechanisms, and clinical impact of bacterial heteroresistance","volume":"3","author":"Xu","year":"2025","journal-title":"NPJ Antimicrob. Resist."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1093745","article-title":"A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.353","article-title":"Mycobacterium tuberculosis : Pathogenesis and therapeutic targets","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"B115","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12941-021-00478-z","article-title":"Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis","volume":"20","author":"Ye","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1128\/JCM.02489-13","article-title":"Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB\/RIF are associated with poor clinical outcomes","volume":"52","author":"Zetola","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01884-22","article-title":"Quantification of isoniazid-heteroresistant Mycobacterium tuberculosis using droplet digital PCR","volume":"61","author":"Zhang","year":"2023","journal-title":"J. Clin. Microbiol."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00483-25","article-title":"Rapid detection of rifampin resistance in Mycobacterium tuberculosis using nucleotide MALDI-TOF MS: a comparative study with phenotypic drug susceptibility testing and DNA sequencing","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1128\/jcm.03507-14","article-title":"Mixed infections and rifampin heteroresistance among Mycobacterium tuberculosis clinical isolates","volume":"53","author":"Zheng","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.2147\/IDR.S381097","article-title":"Highly sensitive detection of isoniazid heteroresistance in Mycobacterium tuberculosis by droplet digital PCR","volume":"15","author":"Zheng","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B122","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2021.04.027","article-title":"Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study","volume":"108","author":"Zhu","year":"2021","journal-title":"Int. J. Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1894646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:41:29Z","timestamp":1784695289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1894646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":113,"alternative-id":["10.3389\/fcimb.2026.1894646"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1894646","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1894646"}}